Cancer researchers identify potential new class of drugs to treat blood and bone marrow cancers

CLEVELAND – A new study by researchers in Cleveland Clinic’s Taussig Cancer Institute and Lerner Research Institute describes a novel class of targeted cancer drugs that may prove effective in treating certain common types of leukemia. The results first appeared online in Blood Cancer Discovery. Myeloid leukemias are cancers derived from stem and progenitor cells…

UC Riverside School of Medicine to serve as lead site for clinical trial on stuttering

RIVERSIDE, Calif. — The School of Medicine at the University of California, Riverside, will serve as lead site for a Phase 2 clinical trial evaluating ecopipam, an investigational first-in-class drug being tested for the treatment of stuttering in adults and Tourette syndrome in pediatric patients. Emalex Biosciences Inc., a clinical-stage biopharmaceutical company that developed ecopipam,…

Kernels of history

Earlier this year Douglas J. Kennett, a UC Santa Barbara professor of anthropology, demonstrated that maize, or corn, became a staple crop in the Americas 4,700 years ago. It turns out he was just beginning to tell the story of the world’s biggest grain crop. In a new paper in the Proceedings of the National…